Search

everythinglearnresearchcommunity

for

Search:↓

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

A woman's significant hair loss was linked to rapid weight loss and hormone injections.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Cosmetic foam product reduces hair loss and increases hair density in men.

Hair is thinner near the scalp in acute hair shedding conditions.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

No significant difference in iron deficiency between women with or without hair loss.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Hair shedding is an active process that could be targeted to treat hair loss.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The dietary supplement helped increase hair growth in women with hair loss.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Signaling pathways are crucial for hair growth in goats.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Macrophage-stimulating protein helps hair grow and can start hair growth phase in mice and human hair samples.

Telogen is an active phase with important biological processes, not a resting phase.

Minoxidil treatment may cause hair loss.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.